Spots Global Cancer Trial Database for navelbine
Every month we try and update this database with for navelbine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | NCT00146549 | Breast Cancer Stage IV Breast... | Trastuzumab Vinorelbine Paclitaxel Docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) | NCT00890903 | Non Small Cell ... Metastatic Brea... | 18 Years - | Pierre Fabre Pharma GmbH | ||
Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer | NCT02489409 | Breast Neoplasm... | EndostarTM Inje... Gemcitabine Navelbine Platinum Xeloda Tablets: | 18 Years - 70 Years | Xinjiang Medical University | |
Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer | NCT01020864 | Head and Neck N... | Cetuximab Carboplatin Vinorelbine | 18 Years - 80 Years | Odense University Hospital | |
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer | NCT00153907 | Breast Cancer | Navelbine Capecitabine | 18 Years - | Dana-Farber Cancer Institute | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00004093 | Lung Cancer | carboplatin Gemcitabine paclitaxel vinorelbine radiation thera... Navelbine Taxol | 18 Years - | Northwestern University | |
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) | NCT00890903 | Non Small Cell ... Metastatic Brea... | 18 Years - | Pierre Fabre Pharma GmbH | ||
Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer | NCT01941771 | Breast Cancer | Arm B Vinorelbi... Arm A Vinorelbi... | 18 Years - | University of Aarhus | |
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases | NCT01305941 | HER-2 Positive ... | Everolimus Vinorelbine Trastuzumab | 21 Years - | UNC Lineberger Comprehensive Cancer Center | |
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | NCT00632827 | Peripheral T-Ce... | Gemcitabine Navelbine Doxorubicin Hyd... Granulocyte-col... Pegfilgrastim Cyclophosphamid... Vincristine Leucovorin Methotrexate Doxorubicin Hyd... Cytarabine Etoposide Carmustine Denileukin dift... | 18 Years - 70 Years | University of California, San Francisco | |
Preoperative Herceptin and Navelbine for Breast Cancer | NCT00148681 | Breast Cancer Stage II Breast... Stage III Breas... | Herceptin Navelbine Doxorubicin Cyclophosphamid... Paclitaxel | 18 Years - | Dana-Farber Cancer Institute | |
Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer | NCT01941771 | Breast Cancer | Arm B Vinorelbi... Arm A Vinorelbi... | 18 Years - | University of Aarhus | |
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | NCT00146549 | Breast Cancer Stage IV Breast... | Trastuzumab Vinorelbine Paclitaxel Docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
Preoperative Herceptin and Navelbine for Breast Cancer | NCT00148681 | Breast Cancer Stage II Breast... Stage III Breas... | Herceptin Navelbine Doxorubicin Cyclophosphamid... Paclitaxel | 18 Years - | Dana-Farber Cancer Institute | |
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases | NCT01305941 | HER-2 Positive ... | Everolimus Vinorelbine Trastuzumab | 21 Years - | UNC Lineberger Comprehensive Cancer Center |